Go to deals
Insights & Analytics | Software & Technology

Owler has completed a Series B-1 round fundraising

Owler has raised capital in a Series B-1 round from Morningstar Founder and Executive Chairman, Joe Mansueto, and existing investors, Norwest Venture Partners and Trinity Ventures.

Owler is the world’s largest community-based competitive insights platform and private company database. The company uses cutting-edge AI and machine learning technologies as well as crowdsourcing to provide comprehensive business information and insights.

One of Oaklins' TMT teams in New York advised Owler in this transaction.

Talk to the deal team

Reed Phillips

Managing Partner
New York, United States
Oaklins DeSilva+Phillips

Joanna Stone

Partner
New York, United States
Oaklins DeSilva+Phillips

Ken Sonenclar

Managing Director
New York, United States
Oaklins DeSilva+Phillips

Related deals

Oaklins DeSilva+Phillips represents ProcessUnity in its recent transaction
Software & Technology

Oaklins DeSilva+Phillips represents ProcessUnity in its recent transaction

Oaklins DeSilva+Phillips was pleased to represent our client ProcessUnity, a leading provider of third-party risk management (TPRM) software, in its recently announced transaction with S&P Global.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare Communications & Technology | Insights & Analytics | Marketing Services | Software & Technology

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Banook, backed by Motion Equity, has acquired Fluidda
Healthcare Communications & Technology | Software & Technology

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Learn more